EDMONTON, AB, April 20, 2026 /PRNewswire/ - Nanostics Inc., a precision health company advancing diagnostic innovation through its ClarityDX (R) platform, today announced the publication of a ...
A common method of detecting prostate cancer may not be accurate enough as a reliable screening tool by itself, scientists have warned. The digital rectal exam (DRE) is widely used by medical ...
A common method of detecting prostate cancer may not be accurate enough as a reliable screening tool by itself, scientists have warned. The digital rectal exam (DRE) is widely used by medical ...
With the advent of more reliable and accurate ways to screen for prostate cancer, such as PSA testing and prostate MRI, the authors argue that it is time to stop the “antiquated practice” of the ...
Normal findings in selected men with elevated PSA may justify delaying a second prostate biopsy. Researchers in the Netherlands who examined the value of digital rectal examination (DRE) in prostate ...
A non-DRE, voided urine, genomic assay to diagnose prostate cancer and to assess its aggressiveness.
Comparing NCCN-based risk groups to the PROTEUS definition of high-risk localized prostate cancer to inform peri-operative care.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results